Randomized Clinical Trial
Copyright ©The Author(s) 2017.
World J Gastroenterol. Dec 28, 2017; 23(48): 8615-8625
Published online Dec 28, 2017. doi: 10.3748/wjg.v23.i48.8615
Figure 1
Figure 1 Patient flow diagram. 1Group A received any of the CCE preparation regimen = Baseline subject characteristics, safety analysis, comparisons between Control regimen and Rex et al[1] and between Study regimen and Spada et al[15] for colon capsule completion and transit times. 2Group B excluded subjects who withdrew before capsule ingestion, had a protocol violation, or experienced technical failure of the capsule = Colon cleansing by segment, CCE completion, CCE transit times, polyp detection by colon segment, comparisons between Control regimen and Rex et al[1] for colon cleansing by segment. 3Group C excluded subjects listed above (B), and those with non-visualization of the cecum, right colon, or transverse colon = Colon cleansing for whole colon, polyp detection for the whole colon, comparisons between the Control regimen and Rex et al[1] and between the Study regimen and Spada et al[15] for overall cleansing of the colon. 4Group D excluded subjects listed above (B and C) and those with both inadequate overall colon cleansing and colonic transit time < 40 min = Comparisons between Control regimen and Rex et al[1] and Study regimen and Spada et al[15] for whole colon polyp detection.